GE HealthCare (GEHC) beats earnings but cuts full-year revenue outlook amid China headwinds
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
GE HealthCare (GEHC) PT Raised to $92 at Jefferies
July 31, 2024 3:50 PM EDTJefferies analyst Matthew Taylor raised the price target on GE HealthCare (NASDAQ: GEHC) to $92.00 (from $87.00) while maintaining a Hold rating.
The analyst comments "GEHC reported 2Q24 sales of $4.84B, +1% organic vs cons $4.88B, and EPS of $1.00 (+9%) vs cons $0.98. Orders increased +3%... More
GE HealthCare (GEHC) Tops Q2 EPS by 2c, cuts revenue guidance
July 31, 2024 6:25 AM EDT(Updated - July 31, 2024 6:25 AM EDT)
GE HealthCare (NASDAQ: GEHC) reported Q2 EPS of $1.00, $0.02 better than the analyst estimate of $0.98. Revenue for the quarter came in at $4.84 billion versus the consensus estimate of $4.87 billion.
The company sees full-year EPS between $4.20 and $4.35,... More
